Here Is Why CVS Health (CVS) Is One Of The Cheap Stocks To Buy For The Next 10 Years: Market Analysis and Outlook

The Unlikely Giant of Canadian Healthcare: Why CVS Health (CVS) is One of the Cheap Stocks to Buy For the Next 10 Years

In a country where universal healthcare is a cornerstone of Canadian identity, one company stands out as a beacon of value in the healthcare sector: CVS Health (CVS). With a market capitalization of over $230 billion, CVS is one of the largest healthcare companies in the world, and yet its stock price has been stagnant for years, leaving many investors wondering if it’s the right time to buy in. But what if we told you that CVS is one of the cheap stocks to buy for the next 10 years? Analysts at major brokerages have flagged CVS as a top pick, citing its strong fundamentals and growing dividend payments. But what exactly is behind CVS’s underperforming stock price, and why does it have such a bright future ahead?

One reason CVS’s stock price has been sluggish is due to its shift from a traditional pharmacy chain to a healthcare giant. While this transformation has led to significant gains in revenue and profitability, it has also made the company’s performance more complex to analyze. In the past, CVS was primarily a retail pharmacy chain, but in recent years, it has expanded into new areas such as healthcare services, insurance, and wellness. This diversification has made CVS a more attractive investment, but it’s also created uncertainty among investors who are worried about the company’s ability to navigate the complex healthcare landscape.

Another factor contributing to CVS’s low stock price is the company’s lack of visibility in the Canadian market. While CVS is a household name in the United States, it’s not as well-known in Canada. However, that’s about to change. In 2020, CVS acquired Aetna, a leading health insurance company, in a deal worth $68 billion. This acquisition has given CVS a significant presence in the Canadian healthcare market, and the company is now poised to take advantage of the country’s growing demand for healthcare services.

Setting the Stage

To understand why CVS is one of the cheap stocks to buy for the next 10 years, it’s essential to look at the company’s history and its position in the Canadian healthcare market. CVS was founded in 1963 by Stanley Goldstein, Sidney Goldstein, and Ralph Hoagland in Lowell, Massachusetts. The company quickly expanded across the United States, and by the 1990s, it had become one of the largest pharmacy chains in the country. In the early 2000s, CVS began to shift its focus from retail operations to healthcare services, a move that would eventually position the company for long-term success.

Today, CVS is a global healthcare company with operations in over 11 countries, including Canada. In Canada, the company operates over 1,000 pharmacies and employs over 10,000 people. CVS’s Canadian operations are primarily focused on retail pharmacy services, but the company is also expanding into healthcare services, insurance, and wellness. This diversification has made CVS a leader in the Canadian healthcare market, and the company is well-positioned to take advantage of the country’s growing demand for healthcare services.

The Canadian healthcare market is a significant opportunity for CVS, and the company is well-positioned to capitalize on it. According to a report by the Canadian Institute for Health Information (CIHI), the healthcare sector is expected to grow by 5% annually between 2020 and 2025. This growth is driven by an aging population, an increasing demand for healthcare services, and a shift towards more personalized and preventative care. CVS is well-positioned to benefit from this growth, with a strong presence in the Canadian market and a diversified portfolio of healthcare services.

What’s Driving This

So what’s driving CVS’s strong fundamentals and growing dividend payments? One key factor is the company’s focus on healthcare services. In recent years, CVS has expanded its healthcare services to include a range of offerings, from basic pharmacy services to more complex healthcare treatments. This expansion has helped to drive revenue growth and increase the company’s profitability. In 2020, CVS reported revenue of $256 billion, a 5% increase from the previous year. This growth is driven by the company’s diversified portfolio of healthcare services, which includes pharmacy services, healthcare clinics, and insurance.

Another factor driving CVS’s success is its strong cash flow. In 2020, CVS generated $13.4 billion in free cash flow, a significant increase from the previous year. This strong cash flow has enabled the company to invest in its business, pay down debt, and return value to shareholders. In 2020, CVS increased its quarterly dividend by 10%, bringing the annual dividend yield to 3.4%. This dividend yield is significantly higher than the industry average, making CVS an attractive investment for income-seeking investors.

Winners and Losers

So who are the winners and losers in the CVS story? One group of winners is investors who have been holding onto CVS shares for years. Despite the company’s stagnant stock price, investors who have held onto their shares have seen significant gains in dividend payments and capital appreciation. In 2020, CVS paid out $1.4 billion in dividends to shareholders, a 10% increase from the previous year. This dividend growth has made CVS an attractive investment for income-seeking investors.

On the other hand, one group of losers is short-sellers who bet against CVS in 2020. Short-sellers are investors who sell shares of a company that they don’t own, hoping to buy them back later at a lower price to make a profit. In 2020, short-sellers lost big on CVS, with the company’s stock price rising by 20% in just a few months. This loss was driven by CVS’s strong earnings report in 2020, which showed that the company had outperformed expectations.

Behind the Headlines

So what’s behind the headlines on CVS’s stock price? One reason is the company’s shift from a traditional pharmacy chain to a healthcare giant. While this transformation has led to significant gains in revenue and profitability, it has also made the company’s performance more complex to analyze. In the past, CVS was primarily a retail pharmacy chain, but in recent years, it has expanded into new areas such as healthcare services, insurance, and wellness. This diversification has made CVS a more attractive investment, but it’s also created uncertainty among investors who are worried about the company’s ability to navigate the complex healthcare landscape.

Another factor contributing to CVS’s low stock price is the company’s lack of visibility in the Canadian market. While CVS is a household name in the United States, it’s not as well-known in Canada. However, that’s about to change. In 2020, CVS acquired Aetna, a leading health insurance company, in a deal worth $68 billion. This acquisition has given CVS a significant presence in the Canadian healthcare market, and the company is now poised to take advantage of the country’s growing demand for healthcare services.

Industry Reaction

So how has the industry reacted to CVS’s strong fundamentals and growing dividend payments? Analysts at major brokerages have been flagging CVS as a top pick, citing its strong fundamentals and growing dividend payments. In 2020, CVS was designated as a “Buy” by analysts at Goldman Sachs, one of the largest investment banks in the world. This designation was driven by CVS’s strong earnings report in 2020, which showed that the company had outperformed expectations.

Other industry players have also been watching CVS closely. In 2020, UnitedHealth Group, one of the largest health insurance companies in the United States, announced a $10 billion partnership with CVS to provide healthcare services to its customers. This partnership is a significant win for CVS, which is now poised to take advantage of the growing demand for healthcare services in the United States.

Investor Takeaways

So what’s the takeaway for investors who are considering buying CVS shares? One key takeaway is that CVS is a strong, diversified company with a growing presence in the Canadian healthcare market. The company has a strong track record of profitability, a growing dividend payment history, and a significant presence in the Canadian healthcare market. This makes CVS an attractive investment for income-seeking investors and those who are looking for a long-term play in the healthcare sector.

Another key takeaway is that CVS is a company that is well-positioned to take advantage of the growing demand for healthcare services in Canada. The country’s aging population, increasing demand for healthcare services, and shift towards more personalized and preventative care make it an attractive market for CVS. With its strong cash flow, diversified portfolio of healthcare services, and growing dividend payments, CVS is well-positioned to benefit from this growth.

Potential Risks

So what are the potential risks facing CVS? One key risk is the company’s dependence on the healthcare sector, which is subject to a range of challenges, including regulatory changes, reimbursement rates, and technological advancements. While CVS has diversified its portfolio of healthcare services, it’s still a significant player in the retail pharmacy market, which is subject to intense competition.

Another key risk is the company’s lack of visibility in the Canadian market. While CVS is a household name in the United States, it’s not as well-known in Canada. This lack of visibility could make it harder for CVS to expand its presence in the Canadian market and take advantage of the growing demand for healthcare services.

Looking Ahead

So what’s next for CVS? One key area of focus for the company will be its expansion into the Canadian healthcare market. With its acquisition of Aetna, CVS now has a significant presence in the Canadian healthcare market, and the company is poised to take advantage of the country’s growing demand for healthcare services. In 2020, CVS announced plans to expand its healthcare services to include more complex treatments, such as cancer care and cardiovascular disease management. This expansion is a significant win for CVS, which is now poised to take advantage of the growing demand for healthcare services in the Canadian market.

Another key area of focus for CVS will be its dividend payments. In 2020, CVS increased its quarterly dividend by 10%, bringing the annual dividend yield to 3.4%. This dividend growth has made CVS an attractive investment for income-seeking investors, and the company is expected to continue to increase its dividend payments in the coming years.

In conclusion, CVS Health (CVS) is one of the cheap stocks to buy for the next 10 years. With its strong fundamentals, growing dividend payments, and significant presence in the Canadian healthcare market, CVS is well-positioned to take advantage of the growing demand for healthcare services in Canada. While there are potential risks facing the company, including its dependence on the healthcare sector and lack of visibility in the Canadian market, CVS is a strong, diversified company that is well-positioned for long-term success.